Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

New approach for the rational and automated design of ligands against multiple drug targets

Dec. 28, 2012

Halozyme Therapeutics and Pfizer to develop recombinant human hyaluronidase biologics

Dec. 27, 2012

TLS obtains IND clearance for clinical trial protocol based on crowdsourcing

Dec. 24, 2012

Arrowhead and Shire enter agreement to develop peptide-targeted therapeutics

Dec. 20, 2012

Bioengineering of a human lung-on-a-chip model for drug efficacy and toxicity screening

Dec. 19, 2012

Targeted delivery of proteins across BBB disclosed by U.S. team

Dec. 17, 2012

Milestone reached in DuoBody platform collaboration

Dec. 14, 2012

IMI launches new drug development projects

Dec. 7, 2012

uniQure and Benitec Biopharma enter cross-licensing agreement

Dec. 5, 2012

Proof-of-concept of a novel enzyme-based drug delivery system

Dec. 4, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 5, 2025.
NIH changes set industry up for workforce, ideas drought
BioWorld
On March 1, 2025, former NIH director Francis Collins’ announced that he had fully resigned from the NIH, where he continued to lead a laboratory after his...
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for March 5, 2025
Roche looks to grow with sequencing by expansion tech
BioWorld MedTech
Roche Holding AG revealed plans to launch its sequencing by expansion technology next year, raising the possibility that rival Illumina Inc. could face a real run...
Magnet, Eli Lilly sign $1.25B molecular glue deal for oncology
BioWorld
About 17 months after emerging from stealth with its Trueglue discovery platform, Magnet Biomedicine Inc. has joined with Eli Lilly and Co. to discover, develop...